Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 31.48% is 52% above its 5-year average of 20.68%, near the high end of its 5-year range (11.46%–31.48%).
As of the fiscal period ended Tuesday, March 31, 2026. 14.93% above its 12-month average of 27.39%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
31.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
27.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
24.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
20.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
16.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
13.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
11.64%
CURRENT VS TTM AVG
+14.93%
CURRENT VS 3Y AVG
+27.29%
CURRENT VS 5Y AVG
+52.20%
CURRENT VS 10Y AVG
+88.87%
CURRENT VS 15Y AVG
+126.92%
CURRENT VS 20Y AVG
+170.49%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+269.05%
vs the sector median at left
McKesson Corporation
Market Cap
$96.59B
Return on Invested Capital (ROIC)
31.48%
TTM Avg
27.39%
3Y Avg
24.73%
5Y Avg
20.68%
Market Cap
$103.20B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
12.56%
3Y Avg
12.53%
5Y Avg
10.40%
Market Cap
$88.03B
Return on Invested Capital (ROIC)
18.53%
TTM Avg
17.61%
3Y Avg
17.07%
5Y Avg
16.89%
Market Cap
$83.01B
Return on Invested Capital (ROIC)
6.65%
TTM Avg
6.70%
3Y Avg
7.11%
5Y Avg
7.33%
Market Cap
$110.95B
Return on Invested Capital (ROIC)
6.13%
TTM Avg
6.11%
3Y Avg
5.46%
5Y Avg
5.53%
Market Cap
$78.22B
Return on Invested Capital (ROIC)
8.51%
TTM Avg
9.70%
3Y Avg
12.91%
5Y Avg
18.22%
Market Cap
$74.53B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
7.02%
3Y Avg
7.07%
5Y Avg
6.50%
Market Cap
$119.48B
Return on Invested Capital (ROIC)
18.12%
TTM Avg
10.38%
3Y Avg
14.75%
5Y Avg
17.51%
Market Cap
$71.98B
Return on Invested Capital (ROIC)
8.78%
TTM Avg
7.46%
3Y Avg
6.12%
5Y Avg
5.55%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $96.59B | 31.48% | 27.39% | 24.73% | 20.68% |
| GSK plc (GSK)vs › | $103.20B | 16.61% | 12.56% | 12.53% | 10.40% |
| HCA Healthcare, Inc. (HCA)vs › | $88.03B | 18.53% | 17.61% | 17.07% | 16.89% |
| Elevance Health Inc. (ELV)vs › | $83.01B | 6.65% | 6.70% | 7.11% | 7.33% |
| Medtronic plc (MDT)vs › | $110.95B | 6.13% | 6.11% | 5.46% | 5.53% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.22B | 8.51% | 9.70% | 12.91% | 18.22% |
| Cigna Corporation (CI)vs › | $74.53B | 7.35% | 7.02% | 7.07% | 6.50% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $119.48B | 18.12% | 10.38% | 14.75% | 17.51% |
| Boston Scientific Corporation (BSX)vs › | $71.98B | 8.78% | 7.46% | 6.12% | 5.55% |
| Stryker Corporation (SYK)vs › | $130.80B | 8.53% | 10.14% | 10.34% | 10.08% |
ROIC
31.5%
ROE
-219.2%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | 31.48% |
| 2025-03-31 | 23.30% |
| 2024-03-31 | 21.22% |
| 2023-03-31 | 22.92% |
| 2022-03-31 | 11.46% |
| 2021-03-31 | 13.72% |
| 2020-03-31 | 14.80% |
| 2019-03-31 | 5.73% |
| 2018-03-31 | 13.50% |
| 2017-03-31 | 10.86% |
| 2016-03-31 | 14.35% |
| 2015-03-31 | 11.11% |
| 2014-03-31 | 7.22% |
| 2013-03-31 | 12.24% |
| 2012-03-31 | 14.13% |
| 2011-03-31 | 11.53% |
| 2010-03-31 | 12.18% |
| 2009-03-31 | 13.48% |
| 2008-03-31 | 10.84% |
| 2007-03-31 | 10.68% |
| 2006-03-31 | 10.02% |
| 2005-03-31 | 9.50% |
| 2004-03-31 | 9.88% |
| 2003-03-31 | 9.56% |
| 2002-03-31 | 8.22% |
| 2001-03-31 | -8.29% |
| 2000-03-31 | 1.81% |
| 1999-03-31 | 3.11% |
| 1998-03-31 | 6.45% |
| 1997-03-31 | 0.45% |
